echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The results of the volume procurement were announced involving Medtron, Poco and Lepp

    The results of the volume procurement were announced involving Medtron, Poco and Lepp

    • Last Update: 2020-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 10, Qinghai Province issued a notice on the public announcement of the results of the proposed selection of pacemakers for the purchase of pacemakers in public medical institutions, according to the notice of the Office of the Provincial Medical Security Bureau on the publicity of the centralized procurement of medical supplies for public medical institutions in Qinghai Province, the letter on the results of the proposed selection of the centralized procurement of pacemakers by the Federation of Public Medical Institutions, the results of the proposed selection of two-chamber pacemakers with volume were made public.
    Pacemaker is a regular with volume procurement, August 1, Qujing City, Yunnan Province held a high-value medical supplies alliance specific varieties including crown pulse expansion balloon, coronary pulse guide tube, coronary pulse guide wire, double-cavity pacemaker and pacing electrode conductor.
    , according to preliminary estimates, the maximum reduction of this batch collection of single varieties reached 80%.
    the average decline of more than 70%, the average decline of catheter wire more than 40%, of which the average decline of pacemakers more than 20%.
    the current Qinghai Province's volume procurement has not seen a decline, Cypress Blue equipment will continue to pay attention.
    Focus on the management of high-value consumables for high-value supplies, Qinghai on September 1 issued the Qinghai Provincial Governance of high-value medical supplies reform implementation plan notice, the content of Qinghai Province will be in accordance with national instructions, clinical use of large, relatively high unit price, relatively adequate market competition for high-value medical supplies, from production, circulation, procurement, use, payment and supervision and other aspects of comprehensive in-depth management.
    implementation programme will be implemented from 13 September.
    document pointed out that the National Health and Safety Commission announced the key monitoring list of high-value supplies, based on the formation of Qinghai Province's own high-value supplies key management list, by the end of 2020.
    province of Qinghai, all public medical institutions in the province must be centralized procurement platform tender procurement, and encourage private hospitals to participate in the same.
    will actively explore cross-provincial alliance joint bargaining procurement and provincial public medical institutions alliance centralized volume procurement.
    In terms of supplies, medical supplies at all levels of the province will be completely eliminated, all medical supplies allowed to charge patients separately, should be based on the actual purchase price of "zero rate" sales, not to accept the operator's price discounts and other forms of discounts.
    Province encourages all regions to reduce the circulation of high-value medical supplies through the "two-vote system" and other means, and explores the establishment of medical insurance institutions to pay directly for goods.
    province of Qinghai province clearly, the use of medical supplies should be included in the scope of performance appraisal of the unit, strengthen the high-value medical supplies involved in surgical management.
    improve the clinical application management of high-value medical supplies and integrate them into the performance appraisal and evaluation system of public medical institutions.
    to speed up the pilot of pay-per-view (DRGs) reforms related to disease diagnosis.
    to step up medical quality spot checks, carry out special governance actions in key areas, and directly publicize to the public medical institutions that use high-value consumables in violation of the law on the national credit information sharing platform.
    , it is necessary to establish and improve the supervision system in the hospital, strictly prohibit the department to purchase its own, for medical institutions in violation of the line recruitment and use of high-value supplies, medical insurance will refuse to pay.
    For violations of the law in all aspects of high-value supplies, we will establish and improve a multi-sectoral joint disciplinary system, a "black list" system for serious violations, and increase the notification of typical cases involving high-value medical supplies.
    the National Health and Safety Commission this year issued the "National Health and Health Commission Office on the issuance of the first batch of national high-value medical supplies key governance list notice", announced the focus of the management of 18 kinds of high-value supplies.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.